#16
|
|||
|
|||
Äîáðûé äåíü, óâàæàåìûå ñïåöèàëèñòû.
Äâà äíÿ íàçàä ïåðåñäàâàë àíàëèçû ïîñëå 2õ ìåñÿöåâ ïðèåìà ËÒèðîêñèíà. Ñîñòîÿíèå ìîå íà äàííûé ìîìåíò î÷åíü íåõîðîøåå - óñòàëîñòü, ñîíëèâîñòü, áîëè â ñóñòàâàì, ìûøöàõ - íè÷åãî íå ïðîøëî, à äàæå óñèëèëîñü. Îäíàêî àíàëèçû ïîêàçàëè ÷òî ÒÒã ïðèøëî â íîðìó, àëò è àñò ïðèøëè â íîðìó òîæå, âñå àíàëèçû ïðèêëàäûâàþ. Àíàëèç àíòèòåë ùèòîâèäêèèïîêàçàë ÷òî ó ìåíÿ çàáîëåâàíèå Õàøèìîòî, òàê ñêàçàë ìîé GP. ×òî ñ ýòèì äåëàòü è êàê ëå÷èòü íå ïîíÿë. Îí ñêàçàë ïðèíèìàòü äàëüøå Ëòèðîêñèí 50, à ÷åðåç äåíü Ëòèðîêñèí 75. Ñîñòîÿíèå óæàñíîå. Íî íå çíàþ ñâÿçàíî ëè ýòî äî ñèõ ïîð ñ ùèòîâèäíîé æåëåçîé. Åäèíñòâåííîå, ÿ ÷åñòíî çàáûë ïîïðîñèòü àíàëèç íà êîðòèçîë (( Êàêîé ïëàí ìîåé äàëüíåéøåé òåðàïèè? Ñïàñèáî îãðîìíîå. |
#17
|
||||
|
||||
Àóòîèììóííûé òèðåîèäèò- îí æå òèðåîèäèò Õàøèìîòî- ñàìàÿ ÷àñòàÿ ïðè÷èíà ïåðâè÷íîãî ãèïîòèðåîçà, ýòî GP cêàçàë?
Áåññïîðíî, óæàñíîå ñîñòîÿíèå íèêàê íå ñâÿçàíî ñ ïàòîëîãèåé ùèòîâèäíîé æåëåçû
__________________
Ã.À. Ìåëüíè÷åíêî |
#18
|
||||
|
||||
îáøèé àíàëèç êðîâè èìååòñÿ?
ïðè àóòîèììóííîì ãèïîòèðîçå èìååòñÿ 27% ðèñê äåôèöèòà âèòàìèíà Â12 èç-çà íàëè÷èÿ àíòèïàðèåòàëüíûõ àíòèòåë ( àóòîèìóííûé àòðîôè÷åñêèé ãàñòðèò), îí ìîæåò äàâàòü ïîõîæóþ ñèìïòîìàòèêó è ìàñêèðîâàòü äåôèöèò æåëåçà ÷åðåç ïîâûøåíèå ôåððèòèíà è ñûâîð. æåëåçà: The frequency of vitamin B12 deficiency in patients with hypothyroidism was 27.0% frequency of vitamin B12 deficiency in subclinical hypothyroidism was 27.0% Anti-parietal cell antibodies and autoimmune thyroid disease to be present in 27.0% Vitamin B12 levels in thyroid disorders: A systematic review and meta-analysis 2023
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#19
|
|||
|
|||
Öèòàòà:
Ïî ùèòîâèäíîé æåëåçå ó÷èòûâàÿ äèíàìèêó òåðàïèÿ îñòàåòñÿ ïðîñòî Ëòèðîêñèí 50? Èëè êàê ñêàçàë gp ÷åðåäîâàòü 50/75 ÷åðåç äåíü? Æèòü â ñâîè 35 áóäó äàëüøå? 😀 Öèòàòà:
|
#20
|
|||
|
|||
Öèòàòà:
|
#21
|
||||
|
||||
Öèòàòà:
Îá îïòèìàëüíîé äîçå ïîìîãàåò óçíàòü ÒÒÃ
__________________
Ã.À. Ìåëüíè÷åíêî |
#22
|
|||
|
|||
Öèòàòà:
Ëàäíî, ïðîäîëæàþ äàëüøå ïðèíèìàòü Ëòèðîêñèí. |
|
#23
|
||||
|
||||
äåôèöèòà â12 íåò, ìîæåò áûòü íåäîñòàòîê, íî áåç ãîìîöèñòåèíà èëè ìåòèë-ìàëîíàòà åãî íå âèäíî; ãåìîãëîáèí ó íóæíåé ãðàíèöû íîðìû âðîñëîãî ìóæ÷èíû 140-175, è åñëè âàø ãåìîãëîáèí äîëæåí áûòü â íîðìå 150-155 êàê ó áîëüøèíñòâà çäîðîâûõ ìóæ÷èí, ãåìîãëîáèí 142 ìîæåò âàìè îøóøàòüñÿ êàê àíåìè÷íûé
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |